CPC Biotech Virtual Pharma Expo May 2026: Aseptic Fill/Finish Manufacturing & Packaging

Achieving compliance with Annex 1 regulations requires a rigorous approach to maintaining closed systems, particularly during final fill-finish operations. After passing the final sterilizing-grade filter, how the equipment is linked directly impacts contamination risks. While traditional aseptic connections provide a functionally closed system, they necessitate high-classification cleanrooms or secondary sterilization steps.

Conversely, mechanical intrinsic sterile connection devices offer a fully closed alternative. By utilizing a removable sterile barrier, these devices safely isolate the fluid pathway from the external environment, allowing secure connections to be made even in lower-grade cleanroom environments without supplementary sterilization. Evaluating these components involves a strict review of material compatibility, functional validation data, and comprehensive quality metrics. Discover how to safely safeguard single-use system integrity and satisfy regulatory expectations by accessing the full tech expo presentation video.

About CPC Biotech:

CPC Biotech (Colder Products Company) is the leader in single-use connection technology, offering a wide variety of cell and gene therapy connection solutions that ensure ease of use and a robust connection. Single-use technologies (SUT) save time and labor during set-up and between cycles by eliminating steps, costs of cleaning, sterilization, and cross-contamination between batches. CPC connectors have been tested and validated to comply with accepted industry standards for mechanical strength, extractables and leachables, bacterial ingress, and others. Learn more about the MicroCNX™ connectors and our entire portfolio at cpcworldwide.com/cgt to help you connect with confidence.